Johnson & Johnson, a global healthcare company, has recently been in the spotlight due to controversies surrounding their talc products....
Johnson & Johnson, a leading pharmaceutical company, continues to make waves in the industry with its latest submission of sNDA for the schizophrenia drug CAPLYTA to the FDA....
Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....
Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....
Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....
Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....
Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....
Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....
Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....
Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....
JNJ Johnson & Johnson, a renowned pharmaceutical and consumer goods company, faces a major setback as the US government steps in to block JJ Talc's bankruptcy resolution....
Abbott Laboratories (NYSE:ABT) is catching the attention of investors, including Diamond Hill Capital, as one of their top stock picks....
Despite recent market weakness, pharmaceutical giant Merck & Co., Inc. (NYSE: MRK) remains a strong investment opportunity....
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has announced that it will be revealing its fourth quarter and full-year 2024 financial results on February 10....
Biogen Inc., a leading biotechnology company, is facing a setback as Stifel downgrades its stock due to uncertainty surrounding the launch of its Alzheimer's drug....